Tue, May 6, 7:12 PM (5 days ago)
**Artivion, Inc. (AORT) Q1 2025 Financial Performance Summary** **Revenue and Profit Margins:** - **Revenue:** $98.98 million, up 2% from Q1 2024. - **Products:** $78.80 million, up 11%. - **Preservation Services:** $20.18 million, down 23%. - **Gross Margin:** $63.58 million, up 1%. - **Operating Income:** $2.15 million, down from $25.31 million in Q1 2024. - **Net Loss:** $0.51 million, compared to a net income of $7.53 million in Q1 2024. **Cash Flow:** - **Net Cash Used in Operating Activities:** $16.95 million, up from $5.49 million in Q1 2024. - **Capital Expenditures:** $3.64 million, consistent with Q1 2024. **Earnings Changes:** - **EPS (Basic):** $(0.01), down from $0.18 in Q1 2024. - **EPS (Diluted):** $(0.01), down from $0.18 in Q1 2024. **Operating Expenses:** - **General, Administrative, and Marketing:** $54.70 million, up 78%. - **Research and Development:** $6.73 million, down 3%. **Debt and Liquidity:** - **Total Debt:** $314.61 million. - **Cash and Cash Equivalents:** $37.69 million, down from $53.46 million in Q4 2024. **Uncertainties and Future Operations:** - **Cybersecurity Incident:** Impacted revenue and operations. - **Foreign Exchange Rates:** Affected revenue, particularly in Europe. - **Endospan Agreements:** Valuation adjustments and potential future impacts. - **Regulatory and Market Risks:** Including FDA approvals and global economic conditions. **Segment Performance:** - **Medical Devices:** Revenue up 11%, driven by aortic stent grafts and On-X products. - **Preservation Services:** Revenue down 23%, impacted by a backlog due to the cybersecurity incident. **Geographic Performance:** - **North America:** Revenue down 6%. - **EMEA:** Revenue up 14%. - **APAC:** Revenue up 8%. - **LATAM:** Revenue up 26%. **Forward-Looking Statements:** - **Risks:** Include public health crises, economic downturns, regulatory changes, and supply chain disruptions. - **Strategic Initiatives:** Focus on R&D, product launches, and global expansion. **Conclusion:** Artivion faced challenges in Q1 2025, including a cybersecurity incident and foreign exchange impacts. Despite these headwinds, the company saw growth in key product segments and continues to invest in strategic initiatives. The outlook remains cautious, with a focus on navigating regulatory and market uncertainties.